CCIA
GILD icon

Campbell & Co Investment Adviser’s Gilead Sciences GILD Stock Holding History

Campbell & Co Investment Adviser’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.05M Buy
50,560
+39,149
+343% +$5.48M 0.4% 35
2025
Q4 		$1.4M Sell
11,411
-1,191
-9% -$145K 0.07% 441
2025
Q3 		$1.4M Buy
+12,602
New +$1.43M 0.11% 293
2025
Q2 		– Sell
-28,810
Closed -$3.23M – 1244
2025
Q1 		$3.23M Buy
+28,810
New +$2.97M 0.25% 84
2024
Q2 		– Sell
-4,565
Closed -$334K – 1143
2024
Q1 		$334K Sell
4,565
-2,871
-39% -$221K 0.03% 865
2023
Q4 		$602K Buy
7,436
+1,195
+19% +$93K 0.05% 626
2023
Q3 		$468K Buy
+6,241
New +$480K 0.06% 547
2023
Q2 		– Sell
-7,700
Closed -$639K – 973
2023
Q1 		$639K Buy
+7,700
New +$638K 0.12% 321
2020
Q4 		– Sell
-24,790
Closed -$1.57M – 467
2020
Q3 		$1.57M Buy
+24,790
New +$1.72M 1.17% 2
2020
Q1 		– Sell
-10,811
Closed -$702K – 217
2019
Q4 		$702K Buy
10,811
+6,321
+141% +$412K 0.22% 126
2019
Q3 		$285K Buy
+4,490
New +$294K 0.11% 407
2017
Q3 		– Sell
-4,374
Closed -$310K – 395
2017
Q2 		$310K Buy
+4,374
New +$291K 0.29% 133
2016
Q1 		– Sell
-2,400
Closed -$243K – 138
2015
Q4 		$243K Buy
+2,400
New +$250K 1.61% 17
2015
Q1 		– Sell
-3,743
Closed -$353K – 227
2014
Q4 		$353K Buy
+3,743
New +$387K 0.22% 145
2014
Q2 		– Sell
-15,000
Closed -$1.06M – 187
2014
Q1 		$1.06M Sell
15,000
-28,627
-66% -$2.25M 0.43% 79
2013
Q4 		$3.28M Sell
43,627
-8,073
-16% -$562K 0.74% 47
2013
Q3 		$3.25M Sell
51,700
-14,300
-22% -$855K 0.64% 56
2013
Q2 		$3.38M Buy
+66,000
New +$3.44M 0.65% 44

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Campbell & Co Investment Adviser's GILD Position: Q1 2026 in Review

Campbell & Co Investment Adviser increased its Gilead Sciences (GILD) stake by 343% in Q1 2026, buying an estimated $5.48M and bringing the position to 50,560 shares worth $7.05M. The position accounts for 0.4% of the portfolio, ranked #35.

Campbell & Co Investment Adviser first reported a position in GILD in Q2 2013 and has held it in 18 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Campbell & Co Investment Adviser held 50,560 shares of Gilead Sciences worth $7.05M as of Q1 2026.
  • Campbell & Co Investment Adviser bought 39,149 Gilead Sciences shares in Q1 2026, an estimated $5.48M.
  • Gilead Sciences made up 0.4% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #35 holding.
  • Campbell & Co Investment Adviser first reported a position in Gilead Sciences in Q2 2013 and has held it in 18 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.